CAROLINE LEE: Open Payments
NPI 1548773690 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 75 payments from 17 companies in 2025. Trend: 2023 $2,303 · 2024 $2,066 · 2025 $1,917
Food & beverage: $1,818Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $328 |
| PFIZER INC. | 9 | $284 |
| Lilly USA, LLC | 8 | $269 |
| Galderma Laboratories, L.P. | 8 | $195 |
| Janssen Biotech, Inc. | 4 | $166 |
| LEO Pharma Inc. | 5 | $120 |
| Arcutis Biotherapeutics, Inc. | 5 | $90 |
| Botanix SB Inc | 3 | $74 |
| Almirall LLC | 3 | $67 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $60 |
Products named: RINVOQ, CIBINQO, EBGLYSS, NEMLUVIO, TREMFYA, SKYRIZI, Zoryve, LITFULO.
Industry payments across GA — which companies pay providers there.
